Use of glycosylceramides for enhancing the immune response to antigens

Details for Australian Patent Application No. 2008350531 (hide)

Owner Wittycell S.A.S.

Inventors Serra, Vincent

Agent Davies Collison Cave

Pub. Number AU-A-2008350531

PCT Pub. Number WO2009/101475

Priority 60/992,460 05.12.07 US

Filing date 5 December 2008

Wipo publication date 20 August 2009

International Classifications

C07D 309/10 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07H 5/06 (2006.01) Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/101475 Priority application(s): WO2009/101475

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008350535-Fc receptor-binding polypeptides with modified effector functions

2008350481-Power converting device